This understanding paves the way for developing diagnostic and prognostic strategies that leverage the selective intracellular localization patterns of TRPV4 and other mechanosensitive ion channels, ultimately guiding clinical decisions for patients with high-risk DCIS and other cancers. The gene discussed is TRPV4; the disease is cancer.